SNShinichi Nishi

Shinichi Nishi

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Shinichi Nishi has a total of 72 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Primary and Secondary Glomerular Diseases

    by Masaaki Arakawa, Makiko Ueno, Hiroshi Shimada, Shinichi Nishi

    "Primary and Secondary Glomerular Diseases" published on Dec 2022 by American Society of Nephrology.

  • Open Access

    Correction to: Association between expanded criteria for living kidney donors and renal biopsy findings

    by Shunsuke Goto, Hideyo Oguchi, Ken Sakai, Tetsuo Mikami, Daisuke Ichikawa, Masahiko Yazawa, Junki Koike, Kengo Furuichi, Masahiko Kawabata, Hitoshi Yokoyama, et al.

  • Enhanced loading dose of teicoplanin for three days is required to achieve a target trough concentration of 20 μg/mL in patients receiving continuous venovenous haemodiafiltration with a low flow rate

    by Takashi Ueda, Yoshio Takesue, Kazuhiko Nakajima, Kaoru Ichiki, Kaori Ishikawa, Kumiko Yamada, Toshie Tsuchida, Naruhito Otani, Takeshi Ide, Kenta Takeda, et al.


  • Open Access

    Fatal hypoglycemia with ciprofloxacin in a dialysis patient: A case report

    by Aisa Matoi, Mana Taguchi, Shinichi Nishi

    In patients with renal dysfunction, it is important to avoid prescribing fluoroquinolones including ciprofloxacin.


  • Open Access

    Correction to: Validation of the diagnostic criteria for IgG4‑related kidney disease (IgG4‑RKD) 2011, and proposal of a new 2020 version

    by Takako Saeki, Mitsuhiro Kawano, Tasuku Nagasawa, Yoshifumi Ubara, Yoshinori Taniguchi, Motoko Yanagita, Shinichi Nishi, Michio Nagata, Satoshi Hisano, Yutaka Yamaguchi, et al.


  • Open Access

    Granular swollen epithelial cells in the kidney allograft: A clinicopathological study with special emphasis on possible marker for kidney allograft aging

    by Shigeo Hara, Takeshi Ishimura, Masato Fujisawa, Shinichi Nishi, Tomoo Itoh

    Aim: To elucidate the clinicopathological significance of granular swollen epithelial cells (GSECs), which provides histological evidence in the diagnosis of mitochondrial nephropathy, but incidentally observed in renal allografts, we evaluated GSECs as a surrogate histological marker for kidney allograft aging, as previously reported for p16, p21, and β‐galactosidase.Methods: We retrospectively reviewed 426 kidney allograft biopsy specimens diagnosed at our university from January 2009 to April 2015. The prevalence and density of GSECs were compared with an age‐matched control group of 508 native kidney biopsies. GSECs were defined as swollen (>2 times larger than normal renal tubular cells) epithelial cells best observed using Masson trichrome staining. Morphometric analyses were performed using digital microscopy software.Results: The prevalence of GSECs was 7.7% in allograft kidneys and 8.1% in native kidneys. GSECs in kidney allografts were predominantly detected in medullary renal tubules, but not in the Bowman's capsular epithelium or podocytes. GSECs were observed in the following cases; no remarkable changes, n = 11; interstitial fibrosis and tubular atrophy, n = 7; chronic calcineurin inhibitor toxicity, n = 5; antibody‐mediated rejection, n = 3; T cell‐mediated rejection grade IA, n = 1; and others, n = 6. Compared with control specimens, medullary density of GSECs in kidney allografts was significantly increased. The prevalence of GSECs slightly increased with post‐transplant duration; however, this trend was not statistically significant.Conclusions: The present study does not provide pathological significance of GSEC in kidney allografts in terms of allograft aging, and warrant the further research with molecular approach.


  • Evaluation of chest compression effect on airway management with air-Q®, aura-i®, i-gel®, and Fastrack® intubating supraglottic devices by novice physicians: a randomized crossover simulation study

    by Nobuyasu Komasawa, Ryusuke Ueki, Yoshiroh Kaminoh, Shin-Ichi Nishi

    In the 2010 American Heart Association guidelines, supraglottic devices (SGDs) such as the laryngeal mask are proposed as alternatives to tracheal intubation for cardiopulmonary resuscitation. Some SGDs can also serve as a means for tracheal intubation after successful ventilation. The purpose of this study was to evaluate the effect of chest compression on airway management with four intubating SGDs, aura-i® (aura-i), air-Q® (air-Q), i-gel® (i-gel), and Fastrack® (Fastrack), during cardiopulmonary resuscitation using a manikin. Twenty novice physicians inserted the four intubating SGDs into a manikin with or without chest compression. Insertion time and successful ventilation rate were measured. For cases of successful ventilation, blind tracheal intubation via the intubating SGD was performed with chest compression and success or failure within 30 s was recorded. Chest compression did not decrease the ventilation success rate of the four intubating SGDs (without chest compression (success/total): air-Q, 19/20; aura-i, 19/20; i-gel, 18/20; Fastrack, 19/20; with chest compression: air-Q, 19/20; aura-i, 19/20; i-gel, 16/20; Fastrack, 18/20). Insertion time was significantly lengthened by chest compression in the i-gel trial (P < 0.05), but not with the other three devices. The blind intubation success rate with chest compression was the highest in the air-Q trial (air-Q, 15/19; aura-i, 14/19; i-gel, 12/16; Fastrack, 10/18). This simulation study revealed the utility of intubating SGDs for airway management during chest compression.


  • Open Access

    Evaluating the fundamental critical care support course in critical care education in Japan: a survey of Japanese fundamental critical care support course experience

    by Kazuaki Atagi, Shinichi Nishi, Shigeki Fujitani, Takamitsu Kodama, Junya Ishikawa, Hideki Shimaoka

    The Fundamental Critical Care Support (FCCS) course has been introduced after minimal adaptation according to Japanese clinical settings. The original course in the USA is often used to prepare residents for rotations in the intensive care unit (ICU). Therefore, the FCCS program can be appropriate for the basic training of critical care in Japan to standardize critical care management. The purpose of this study is to evaluate whether Japanese FCCS course is useful and has a possibility to deserve a basis of critical care management in Japan. The course program was provided with the form of lecture and skills stations. Pre- and post-training knowledge was assessed. After completion of the 2-day course, a questionnaire survey was administered to all course participants. Participants were asked to fill out the questions regarding socio-demographic characteristics. Participants were also asked to identify which lectures or skill stations they thought to be useful for clinical practice. Then, they were asked to rate their performance of each field: ‘Assessment,’ ‘Diagnosis,’ ‘Recognition,’ ‘Response,’ and ‘Transfer’. The number of participants increased year after year and reached 1,804 during the past 4 years. Nearly 70% of the participants were physicians. Most of the others were nurses. In the established year, the percentage of physicians who had clinical experience more than 5 years exceeded 50%, however, this percentage gradually decreased. On the contrary, the percentages of residents and nurses increased. Regarding useful sessions, nearly half of the participants thought that mechanical ventilation was the most useful. With regard to the results of pre- and post-tests, the participants had already shown a high average mark (78.8 ± 14.1) at the pre-test. Furthermore, the score at the post-test was significantly improved (82.0 ± 6.6, p < 0.01). The participants' confidence in any field regarding critical care management was almost 4 points (5-point scale). It is considered that Japanese FCCS course is useful and has a promising basis of critical care management in Japan. Therefore, it is reasonable to think that Japanese FCCS mission has been successfully achieved.


  • Open Access

    [IgA nephropathy and tonsillectomy].

    by Shinichi Nishi

  • Comparison of Pentax-AWS Airwayscope video laryngoscope, Airtraq optic laryngoscope, and Macintosh laryngoscope during cardiopulmonary resuscitation under cervical stabilization: a manikin study

    by Nobuyasu Komasawa, Ryusuke Ueki, Hanako Kohama, Shin-Ichi Nishi, Yoshiroh Kaminoh

    The 2010 American Heart Association or European Resuscitation Council guidelines for cardiopulmonary resuscitation emphasize that rescuers should minimize interruption of chest compressions, even for endotracheal intubation. Cervical stabilization should also be maintained during traumatic cardiac arrest. The utility of the Pentax-AWS Airwayscope (AWS) video laryngoscope and Airtraq (ATQ) optic laryngoscope for airway management has been reported under cervical stabilization. We first evaluated ATQ utility during chest compression with or without cervical stabilization and then compared the AWS, ATQ, and Macintosh laryngoscope (McL) during chest compressions under cervical stabilization in a manikin. In the first trial, 19 novice doctors performed tracheal intubation with ATQ during chest compression with or without cervical stabilization. In the second trial, 21 novice doctors performed tracheal intubation on a manikin with cervical stabilization using AWS, ATQ, and McL with or without chest compression in a manikin. The rate of successful intubation, time to intubation, and subjective difficulty of use (visual analog scale) were recorded. In the first trial, intubation time during chest compression was significantly shortened under cervical stabilization compared to without cervical stabilization (P < 0.05). In the second trial, using McL, 3 participants failed to perform tracheal intubation without chest compression and 11 failed during chest compression (P < 0.05). Using ATQ, all intubations were successful without chest compression, but 5 failed during chest compression (P < 0.05). Intubation time was significantly prolonged by chest compression using McL or ATQ (P < 0.05). All participants successfully secured the airway with AWS regardless of chest compression, and chest compression did not prolong intubation time. Chest compression worsened the score on the visual analog scale of laryngoscopy in the McL trial (P < 0.05), but not in ATQ or AWS trials. Difficulty of tube passage through the glottis increased with chest compression with the McL and ATQ (P < 0.05) but not with AWS. The AWS was superior to McL and ATQ for endotracheal intubation during simulated cervical stabilization and chest compression.